Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Alergia e Inmunología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Subjects With Immunoglobulin A Nephropathy.
INTERVENTIONAL
Inicio: 15 de mar de 2022
ID: NCT05248646
Completado
Fase 4
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Evaluate the Effects of a One-Year Course of Fluticasone Furoate Nasal Spray 110mcg QD on Growth in Pre-Pubescent, Pediatric Subjects With Perennial Allergic Rhinitis
INTERVENTIONAL
Inicio: 26 de nov de 2007
ID: NCT00570492
Activo, no recluta
Fase 2
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Assess the Efficacy and Safety of Treatment With Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection on Antiretroviral Treatment
INTERVENTIONAL
Inicio: 17 de sept de 2024
ID: NCT06497504
Completado
Fase 3
ClinicalTrials.gov
A Prospective Single Arm, Open-label, International, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Atazanavir (ATV) Powder Boosted With Ritonavir (RTV) With an Optimized NRTI Background Therapy, in Human Immunodeficiency Virus (HIV) Infected, Antiretroviral, Naive and Experienced Pediatric Subjects From 3 Months to Less Than 11 Years.(Pediatric Atazanavir International Clinical Evaluation: the PRINCE II Study)
INTERVENTIONAL
Inicio: 27 de may de 2011
ID: NCT01335698
Completado
Fase 3
ClinicalTrials.gov
A Randomized Double-blind Placebo-controlled Parallel Group Study Assessing the Efficacy and Safety of Dupilumab in Patients With Allergic Fungal Rhinosinusitis (AFRS)
INTERVENTIONAL
Inicio: 1 de dic de 2020
ID: NCT04684524
Desconocido
ClinicalTrials.gov
An Expanded Access Protocol for Subjects Who Have Completed Clinical Studies Involving Maraviroc
EXPANDED_ACCESS
ID: NCT01776996
Reclutando
Fase 2
ClinicalTrials.gov
A Phase 2b, Multi-center, Randomized, Double-blind, Placebo-controlled Study of IMVT-1402 Treatment in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
INTERVENTIONAL
Inicio: 18 de mar de 2025
ID: NCT07032662
Completado
Fase 2
ClinicalTrials.gov
A Randomized, Subject- and Investigator-blinded, Placebo Controlled, Multi-center, Multiple Dose Study to Assess the Efficacy and Safety of CJM112 in Patients With Inadequately Controlled Moderate to Severe Asthma
INTERVENTIONAL
Inicio: 6 de nov de 2017
ID: NCT03299686
Reclutando
Fase 3
ClinicalTrials.gov
A Multicenter Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Zigakibart in Adults With Primary IgA Nephropathy.
INTERVENTIONAL
Inicio: 28 de jul de 2025
ID: NCT06858319
Completado
Fase 4
ClinicalTrials.gov
A Patient Preference Evaluation Study of Fluticasone Furoate Nasal Spray and Mometasone Furoate Nasal Spray in Subjects With Allergic Rhinitis
INTERVENTIONAL
Inicio: 26 de mar de 2015
ID: NCT02397915
Reclutando
Fase 2
ClinicalTrials.gov
A Multicenter, Single Arm, Open Label Biopsy Study to Evaluate Structural and Functional Changes in Kidneys of Adult Patients With IgA Nephropathy Receiving Iptacopan on Top of Supportive Care
INTERVENTIONAL
Inicio: 21 de feb de 2025
ID: NCT06797518
Terminado
Fase 2
ClinicalTrials.gov
A Phase IIa, Randomized, Double-blind, Active-controlled, 12-week Study of Amdoxovir (Two Doses) Versus Tenofovir DF, in Combination With Zidovudine in HIV-1 Treatment-experienced Subjects With M184I/V Mutation in Addition to 0-2 Confirmed Thymidine Analog Mutations.
INTERVENTIONAL
Inicio: 1 de dic de 2012
ID: NCT01737359
Reclutando
Fase 3
ClinicalTrials.gov
Prospective, Randomised, DBPC, Multicenter Clinical Trial to Evaluate Efficacy and Safety of Sublingual Immunotherapy in Patients With Rhinitis/Rhinoconjunctivitis With or Without Mild to Moderate Asthma, Allergic to Dpt and/or Df
INTERVENTIONAL
Inicio: 2 de abr de 2025
ID: NCT07348302
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current INI- NNRTI-, or PI-based Antiretroviral Regimen in HIV-1-infected Adults Who Are Virologically Suppressed
INTERVENTIONAL
Inicio: 28 de oct de 2016
ID: NCT02951052
Completado
Fase 3
ClinicalTrials.gov
An Open Label, Single Arm Study to Assess the Safety and Immunogenicity of Omalizumab Liquid Administered Subcutaneously to Male and Female Adolescents and Adults With Persistent Allergic Asthma
INTERVENTIONAL
Inicio: 1 de jul de 2007
ID: NCT00500539
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind Study of the Safety and Efficacy of GSK1349572 50 mg Once Daily Versus Raltegravir 400 mg Twice Daily, Both Administered With an Investigator-selected Background Regimen Over 48 Weeks in HIV-1 Infected, Integrase Inhibitor-Naïve, Antiretroviral-Experienced Adults
INTERVENTIONAL
Inicio: 26 de oct de 2010
ID: NCT01231516
Reclutando
Fase 2
ClinicalTrials.gov
A Phase 2 Randomized, Double-blind Placebo-Controlled Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety and Efficacy of WIN378 in Adult Participants With Moderate or Severe Asthma
INTERVENTIONAL
Inicio: 24 de jul de 2025
ID: NCT07120503
Completado
ClinicalTrials.gov
Immunity Against the COVID-19 Vaccine in Healthcare Workers of Buenos Aires, Argentine.
OBSERVATIONAL
Inicio: 9 de abr de 2021
ID: NCT04843917
Completado
Fase 2
ClinicalTrials.gov
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Dosing Regimens of MEMP1972A in Adults With Allergic Asthma Who Are Inadequately Controlled on Inhaled Corticosteroids and a Second Controller (COSTA)
INTERVENTIONAL
Inicio: 1 de abr de 2012
ID: NCT01582503
Completado
Fase 3
ClinicalTrials.gov
Multicenter, Randomized, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy and Safety of IGIV-Chromatography (IGIV-C), 10% Treatment in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy
INTERVENTIONAL
Inicio: 1 de abr de 2004
ID: NCT00220740
Anterior
1
2
3
...
434
Siguiente
Filtros